{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:56Z","timestamp":1786119296612,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/dad.0b013e31818d0796","type":"journal-article","created":{"date-parts":[[2009,6,16]],"date-time":"2009-06-16T04:11:41Z","timestamp":1245125501000},"page":"475-479","source":"Crossref","is-referenced-by-count":4,"title":["Resolution of CD8+ Lymphomatoid Papulosis After Surgical Excision of the Type AB-Thymoma"],"prefix":"10.1097","volume":"31","author":[{"given":"Aieska de","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence E","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee S","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokea","family":"el-Azhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana N","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant.","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"key":"R2-14-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0190-9622(83)70011-3","article-title":"The clinico-pathologic spectrum of lymphomatoid papulosis: study of 31 cases.","volume":"8","author":"Sanchez","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"R3-14-20210202","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0190-9622(94)70019-2","article-title":"Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies.","volume":"30","author":"El-Azhary","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"R4-14-20210202","first-page":"630","article-title":"Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.","volume":"139","author":"Basarab","year":"1998","journal-title":"Br J Dermatol"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1993.01680240091015","article-title":"Lymphomatoid papulosis and associated lymphomas: how are they related?","volume":"129","author":"Kadin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD 30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R7-14-20210202","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.","volume":"12","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes.","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-14-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/0001555567351356","article-title":"Dermatologic disorders in patients with thymoma.","volume":"67","author":"Gibson","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"R12-14-20210202","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1523-1747.2003.12563.x","article-title":"The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders.","volume":"121","author":"Schon","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R13-14-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.1808","article-title":"Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development.","volume":"207","author":"Strobel","year":"2005","journal-title":"J Pathol"},{"key":"R14-14-20210202","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.10.001","article-title":"Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.","volume":"172","author":"Suzuki","year":"2006","journal-title":"J Neuroimmunol"},{"key":"R15-14-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2005.06905.x","article-title":"The new World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas: a practical marriage of two giants.","volume":"153","author":"Slater","year":"2005","journal-title":"Br J Dermatol"},{"key":"R16-14-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0190-9622(08)80970-X","article-title":"T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.","volume":"25","author":"Zelickson","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"R17-14-20210202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1309\/NNV4L5G5A0KF1T06","article-title":"CD8+ lymphomatoid papulosis and its differential diagnosis.","volume":"125","author":"Magro","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R18-14-20210202","first-page":"563","article-title":"Lymphomatoid papulosis in an HIV positive man.","volume":"18","author":"Weinstein","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"R19-14-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1525-1470.2003.20211.x","article-title":"Two cases of lymphomatoid papulosis in children.","volume":"20","author":"Aoki","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"R20-14-20210202","first-page":"1","article-title":"IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils.","volume":"4","author":"Slone","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R21-14-20210202","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemeze","year":"2005","journal-title":"Blood"},{"key":"R22-14-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00019606-200309000-00004","article-title":"The utility of the in situ detection of T-cell receptor beta rearrangements in cutaneous T-cell-dominant infiltrates.","volume":"12","author":"Magro","year":"2003","journal-title":"Diagn Mol Pathol"},{"key":"R23-14-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","article-title":"Chemokine receptor expression in cutaneous T cell and NK\/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.","volume":"30","author":"Yagi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R24-14-20210202","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2133.2005.07039.x","article-title":"Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.","volume":"154","author":"Yamaguchi","year":"2006","journal-title":"Br J Dermatol"},{"key":"R25-14-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases.","volume":"43","author":"Saeki","year":"2006","journal-title":"J Dermatol Sci"},{"key":"R26-14-20210202","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2002-07-2348","article-title":"CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.","volume":"101","author":"Soler","year":"2003","journal-title":"Blood"},{"key":"R27-14-20210202","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.MP.0000021006.53593.B0","article-title":"Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkins disease.","volume":"15","author":"Vermeer","year":"2002","journal-title":"Mod Pathol"},{"key":"R28-14-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R29-14-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R30-14-20210202","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molimm.2004.06.040","article-title":"Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.","volume":"42","author":"Ebert","year":"2005","journal-title":"Mol Immunol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000372-200907000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:46Z","timestamp":1786038646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-200907000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31818d0796","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}